Biotech Values

[jq1234]

I think the market is extrapolating abiraterone data to same setting as docetaxel + OGX011 eventually. Abiraterone data came out on the lower end of expectation, it wouldn't knock out docetaxel + OGX011. First Provenge, then abiraterone put lots of pressure on OGXI stock price this year. I think people realized once they knew everything, these 3 have different mechanism of action, will not replace each other because PC is a big market.